Journal
HEART FAILURE REVIEWS
Volume 23, Issue 3, Pages 469-479Publisher
SPRINGER
DOI: 10.1007/s10741-017-9667-7
Keywords
Heart failure; Diabetes; Oral antidiabetic drugs; Biguanides; Sulfonylureas; Thiazolidinediones; Alpha-glucosidase inhibitors; GLP-1 agonists; SGLT-2 inhibitors
Categories
Ask authors/readers for more resources
Recently, great attention is paid to cardiovascular impact of non-insulin glucose-lowering drugs, particularly in terms of major cardiovascular events and risk of heart failure. In this regard, a surprising diversity among different molecules within the same pharmacological class has been noticed, yielding to an intra-class discrepancy which has no analogous in other cardiovascular fields. The aim of this paper is to review the literature, giving an insight of the heterogeneous effects among groups and within group shown by oral antidiabetic drugs, with a special concern to fragile patients, such as those with or at risk of heart failure.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available